To date, most studies have focused on controlling the VEGF-A/VEGFR-2 axis to alleviate diseases such as retinopathy and cancer;6 therefore, we determined whether 6SG also affects tumor angiogenesis using mouse models of NSCLC and colorectal cancer. This evidence concerns the gene VEGFA and neoplasm.